Idanwo ti o sopọ mọ itọsọna · Alabọde Ipele
AI ni Aabo Oògùn ati Idanwo Pharmacovigilance
Review adverse-event reports, signal detection and standardized coding in drug-safety surveillance workflows across products.
Ibeere 1 ti 8
Kini ibi-afẹde akọkọ ti iṣọra elegbogi?
Awotẹlẹ gbogbo ibeere8 ibeere
Awọn idahun ati awọn alaye han bi o ṣe n mu ibeere naa.
- Kini ibi-afẹde akọkọ ti iṣọra elegbogi?
- Ṣiṣawari, ṣe ayẹwo, ati idilọwọ ipalara lati awọn oogun lẹhin lilo wọn
- Tita awọn oogun tuntun si awọn dokita
- Eto awọn soobu owo ti oogun
- Iṣakojọpọ egbogi apẹrẹ
- Ninu eto NLP ile-iwosan n2c2 ti a tẹjade, alaye wo ni eto naa jade lati awọn akọsilẹ alaye?
- Only patients’ handwritten signatures
- Medication and adverse-event concepts and their relations
- Only final regulatory decisions
- Only medicine prices
- Kí ni ìtúpalẹ̀ àìbáradé ṣe rí nínú àwọn ibi data data ìṣẹ̀lẹ̀ búburú?
- Iyatọ idiyele laarin ami iyasọtọ ati awọn oogun jeneriki
- Ile-iwosan wo ni o fi awọn ijabọ julọ silẹ
- Awọn orisii oogun-iṣẹlẹ royin diẹ sii nigbagbogbo ju aye iṣiro lọ yoo sọtẹlẹ
- Awọn ọjọ ipari ti awọn oogun
- Kini VigiBase, ni ibamu si Ile-iṣẹ Abojuto Uppsala?
- A database of randomized clinical-trial efficacy results only
- A list of confirmed causal side effects for every medicine
- A commercial catalogue of approved drug prices
- The WHO global database of reported adverse events for medicines and vaccines
- Kini MedDRA ti a lo fun ni awọn opo gigun ti elegbogi?
- A idiwon egbogi fokabulari fun ifaminsi awọn aati ati awọn ipo
- A brand ti elegbogi apoti
- Ohun elo ṣiṣe eto fun awọn dokita
- Iru ti MRI scanner
- Which sequence does UMC describe in its signal-management process?
- Diagnosis, prescription, dispensing, billing and discharge
- Detection, validation, prioritisation, assessment and communication
- Data collection, automatic causality decision, recall and litigation
- Model training, deployment, billing and marketing
- How should a high disproportionality score in a spontaneous-report database be interpreted?
- As a population incidence rate for all patients
- As a confirmed causal adverse reaction
- As a statistical signal for further assessment, not proof that the drug caused the event
- As proof that no other factor contributed
- Which four elements satisfy the minimum ICSR criteria in ICH E2D(R1)?
- A confirmed causal link, a batch number, a prescriber signature, and a laboratory result
- A product label, a randomized trial, a treatment response, and a safety committee vote
- A hospital admission, a known dose, a genetic profile, and a published case report
- An adverse event or other observation, a suspect or interacting product, an identifiable patient, and an identifiable reporter